2024-07-30 Exercise | 2024-08-01 4:54 pm | N/A N/A | ELUTIA INC. | ELUT | HighCape Capital L.P. Zuga Matt RAKIN KEVIN HighCape Partners GP LLC HighCape Partners GP L.P. HIGHCAPE PARTNERS L.P. HIGHCAPE PARTNERS QP L.P. HighCape Partners QP II L.P. HighCape Partners GP II LLC HighCape Partners GP II L.P. Director 10% Owner | 2,101,577 | $1.4275 | 9,100,232 (Indirect) | View |
2024-07-30 Exercise | 2024-08-01 4:54 pm | 2023-09-21 N/A | ELUTIA INC. | ELUT | HighCape Capital L.P. Zuga Matt RAKIN KEVIN HighCape Partners GP LLC HighCape Partners GP L.P. HIGHCAPE PARTNERS L.P. HIGHCAPE PARTNERS QP L.P. HighCape Partners QP II L.P. HighCape Partners GP II LLC HighCape Partners GP II L.P. Director 10% Owner | 2,101,577 | $0 | 9,100,232 (Indirect) | View |
2024-06-06 Option Award | 2024-06-10 5:00 pm | N/A 2034-06-05 | ELUTIA INC. | ELUT | Zuga Matt Director 10% Owner | 31,835 | $0 | 31,835 (Direct) | View |
2023-12-28 Other | 2024-01-08 4:09 pm | 2023-09-21 N/A | ELUTIA INC. | ELUT | HighCape Capital L.P. Zuga Matt RAKIN KEVIN HighCape Partners GP LLC HighCape Partners GP L.P. HIGHCAPE PARTNERS L.P. HIGHCAPE PARTNERS QP L.P. HighCape Partners QP II L.P. HighCape Partners GP II LLC HighCape Partners GP II L.P. Director 10% Owner | 3,590,193 | $0 | 10,536,309 (Indirect) | View |
2024-01-02 Option Award | 2024-01-04 4:20 pm | N/A 2034-01-01 | Acumen Pharmaceuticals Inc. | ABOS | Zuga Matt CFO & Chief Business Officer | 265,000 | $0 | 374,687 (Direct) | View |
2023-06-08 Option Award | 2023-06-12 3:32 pm | N/A 2033-06-07 | AZIYO BIOLOGICS INC. | AZYO | HighCape Capital L.P. HIGHCAPE PARTNERS L.P. HIGHCAPE PARTNERS QP L.P. HighCape Partners GP LLC HighCape Partners GP L.P. HighCape Co-Investment Vehicle I LLC HighCape Co-Investment Vehicle II LLC HighCape Capital LLC Zuga Matt RAKIN KEVIN Director 10% Owner | 62,500 | $0 | 62,500 (Indirect) | View |
2023-01-17 Option Award | 2023-01-18 4:27 pm | N/A 2033-01-16 | Acumen Pharmaceuticals Inc. | ABOS | Zuga Matt CFO and Chief Business Officer | 184,300 | $0 | 260,487 (Direct) | View |
2022-12-29 Exercise | 2023-01-03 5:23 pm | N/A N/A | Acumen Pharmaceuticals Inc. | ABOS | Zuga Matt CFO and Chief Business Officer | 50,000 | $1.19 | 477,556 (Direct) | View |
2022-12-29 Exercise | 2023-01-03 5:23 pm | N/A 2031-01-03 | Acumen Pharmaceuticals Inc. | ABOS | Zuga Matt CFO and Chief Business Officer | 50,000 | $0 | 477,556 (Direct) | View |
2022-12-22 Option Award | 2022-12-27 6:09 pm | N/A 2032-12-21 | AZIYO BIOLOGICS INC. | AZYO | HighCape Capital L.P. HIGHCAPE PARTNERS L.P. HIGHCAPE PARTNERS QP L.P. HighCape Partners GP LLC HighCape Partners GP L.P. HighCape Co-Investment Vehicle I LLC HighCape Co-Investment Vehicle II LLC HighCape Capital LLC Zuga Matt RAKIN KEVIN Director 10% Owner | 17,533 | $0 | 17,533 (Indirect) | View |
2022-06-07 Option Award | 2022-06-09 08:28 am | N/A 2032-06-06 | AZIYO BIOLOGICS INC. | AZYO | HighCape Capital L.P. HIGHCAPE PARTNERS L.P. HIGHCAPE PARTNERS QP L.P. HighCape Partners GP LLC HighCape Partners GP L.P. HighCape Co-Investment Vehicle I LLC HighCape Co-Investment Vehicle II LLC HighCape Capital LLC Zuga Matt RAKIN KEVIN Director 10% Owner | 44,180 | $0 | 44,180 (Indirect) | View |
2022-01-19 Option Award | 2022-01-21 4:22 pm | N/A 2032-01-19 | Acumen Pharmaceuticals Inc. | ABOS | Zuga Matt CFO and Chief Business Officer | 150,000 | $0 | 150,000 (Direct) | View |
2021-07-06 Conversion | 2021-07-08 6:18 pm | N/A N/A | Acumen Pharmaceuticals Inc. | ABOS | Zuga Matt Chief Financial Officer | 52,374 | $0 | 52,374 (Direct) | View |
Ownership | 2021-06-30 6:52 pm | N/A N/A | Acumen Pharmaceuticals Inc. | ABOS | Zuga Matt Chief Financial Officer | 0 | $0 | 523,976 (Direct) | View |
2021-06-07 Option Award | 2021-06-09 5:44 pm | N/A 2031-06-06 | AZIYO BIOLOGICS INC. | AZYO | HighCape Capital L.P. HIGHCAPE PARTNERS L.P. HIGHCAPE PARTNERS QP L.P. HighCape Partners GP LLC HighCape Partners GP L.P. HighCape Co-Investment Vehicle I LLC HighCape Co-Investment Vehicle II LLC HighCape Capital LLC Zuga Matt RAKIN KEVIN Director 10% Owner | 28,164 | $0 | 28,164 (Indirect) | View |
2020-10-13 Conversion | 2020-10-13 9:57 pm | N/A N/A | AZIYO BIOLOGICS INC. | AZYO | HighCape Capital L.P. HIGHCAPE PARTNERS L.P. HIGHCAPE PARTNERS QP L.P. HighCape Partners GP LLC HighCape Partners GP L.P. HighCape Co-Investment Vehicle I LLC HighCape Co-Investment Vehicle II LLC HighCape Capital LLC Zuga Matt RAKIN KEVIN 10% Owner | 35,196,428 | $0 | 4,540,676 (Indirect) | View |
2020-10-13 Tax Withholding | 2020-10-13 9:57 pm | N/A N/A | AZIYO BIOLOGICS INC. | AZYO | HighCape Capital L.P. HIGHCAPE PARTNERS L.P. HIGHCAPE PARTNERS QP L.P. HighCape Partners GP LLC HighCape Partners GP L.P. HighCape Co-Investment Vehicle I LLC HighCape Co-Investment Vehicle II LLC HighCape Capital LLC Zuga Matt RAKIN KEVIN 10% Owner | 2,451 | $5.4424 | 4,540,676 (Indirect) | View |
2020-10-13 Exercise | 2020-10-13 9:57 pm | N/A N/A | AZIYO BIOLOGICS INC. | AZYO | HighCape Capital L.P. HIGHCAPE PARTNERS L.P. HIGHCAPE PARTNERS QP L.P. HighCape Partners GP LLC HighCape Partners GP L.P. HighCape Co-Investment Vehicle I LLC HighCape Co-Investment Vehicle II LLC HighCape Capital LLC Zuga Matt RAKIN KEVIN 10% Owner | 7,655 | $5.4424 | 4,540,676 (Indirect) | View |
2020-10-13 Exercise | 2020-10-13 9:57 pm | 2017-03-27 2027-03-01 | AZIYO BIOLOGICS INC. | AZYO | HighCape Capital L.P. HIGHCAPE PARTNERS L.P. HIGHCAPE PARTNERS QP L.P. HighCape Partners GP LLC HighCape Partners GP L.P. HighCape Co-Investment Vehicle I LLC HighCape Co-Investment Vehicle II LLC HighCape Capital LLC Zuga Matt RAKIN KEVIN 10% Owner | 7,655 | $0 | 4,540,676 (Indirect) | View |
Ownership | 2020-10-07 9:09 pm | N/A N/A | AZIYO BIOLOGICS INC. | AZYO | HIGHCAPE PARTNERS L.P. HIGHCAPE PARTNERS QP L.P. HighCape Partners GP LLC HighCape Partners GP L.P. HighCape Co-Investment Vehicle I LLC HighCape Co-Investment Vehicle II LLC HighCape Capital L.P. HighCape Capital LLC Zuga Matt RAKIN KEVIN 10% Owner | 0 | $0 | 4,101,951 (Indirect) | View |
Ownership | 2020-09-03 4:45 pm | N/A N/A | HighCape Capital Acquisition Corp. | CAPA | Zuga Matt HighCape Capital Acquisition LLC Director 10% Owner | 0 | $0 | 2,785,000 (Direct) | View |